The nucleophosmin (NPM) gene is involved in two recurrent translocations in hematological malignancies: t(2;5) (p23;q35) in anaplastic large cell lymphoma (ALCL) and t(3;5)(q25.1;q34-35) in myelodysplasia and acute non-lymphocytic leukemia (ANLL). Using eight YACs encompassing the 5q34-q35 region, we could easily detect these two translocations. In both types of translocation, probable unexpected deletions were also discovered downstream of the breakpoint at 5q35.
Introduction
The 2;5 translocation is specifically associated with anaplastic large cell lymphomas (ALCL) of T or null phenotype. 1 The Ki-1 antigen (CD30) expressed by the tumor cells is a marker of activated lymphocytes and of Hodgkin's and Reed-Sternberg cells. 2 The genes disrupted by this translocation are the nucleophosmin gene NPM, located on chromosome 5 and the anaplastic lymphoma kinase (ALK) gene located at 2p23. 3 The NPM gene encodes an ubiquitous nucleolar phosphoprotein involved in the assembly of preribosomal particles, 4, 5 whereas the ALK gene encodes a receptor-type tyrosine kinase normally not expressed in lymphoid tissue. 3 The fusion protein resulting from the translocation, p80, is thought to contribute to malignant transformation in these lymphomas. 6 The NPM gene is also involved in another translocation, the t(3;5)(q25.1;q34-35) found in myelodysplastic syndrome (MDS) and in less than 1% of acute non-lymphoid leukemia (ANLL). 7 In this translocation, the NPM gene is combined with myelodysplasia/myeloid leukemia factor 1 (MLF1) whose function is still unknown. 8 While investigating these two translocations by fluorescent in situ hybridization (FISH) with several YACs covering the 5q34-q35 region, unexpected deletions associated with these translocations were detected in some patients. 10 eight YACs were selected. 928F1, 756A7, 942H4 were centromeric to the breakpoint of the 2;5 translocation in ALCL. 61D1, 885A6 and 925F9 overlapped this breakpoint and 912B5 and 887F10 were more telomeric ( Figure 1 ).
Materials and methods

Patients and cytogenetic diagnosis
Alu-PCR amplification was performed on total yeast DNA as previously described 11 and a labelled nucleotide (biotin 16-dUTP; Boehringer Mannheim, France) was incorporated during PCR.
One of the YACs, amply overlapping the breakpoint (925F9), was purified by pulse field gel electropheresis (PFGE) in a low melting point agarose (1%) for DOP-PCR (degenerated oligonucleotide primers-PCR). Electrophoresis conditions included a 200 V field strength, a 36-h running time and pulses between 60 and 120 s in a 'ramping' mode programme. This YAC was removed from the gel at the expected size (900 kb) and DNA was recovered after heating at 68°C and ␤ agarase treatment (New England Biolabs, Beverly, MA, USA). DOP-PCR was performed as described 12 and biotin-16-dUTP or digoxigenin-11-dUTP (Boehringer Mannheim) was incorporated during the second PCR.
Probes were tested on normal metaphases to confirm localization and absence of chimerism.
FISH
Chromosome preparations from patients and control healthy donors were treated, as previously described.
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Chromosome painting (chromosomes 2, 3 and 5) was performed according to the manufacturer's instructions (Gibco BRL, Paisley, UK; Oncor, Gaithersburg, MD, USA).
One hundred to 150 ng of YAC PCR products were used as probes in the preannealing, hybridization and avidin-FITC amplification conditions were as previously described.
Slides were then examined with a microscope equipped with epifluorescence filters (Zeiss Axiophot, Germany); 20-50 metaphases were analysed per probe and for each experiment. Photographs were taken with a Kodak 400 ASA film and imaging was performed with a CCD camera (Lhesa electronic).
Results and discussion
The 2;5 (patients A and B) and 3;5 (patients C and D) translocations were identified by conventional cytogenetics (R and G banding) and by two-color chromosome painting.
Hybridization with Alu-PCR YAC probes allowed us to confirm the diagnosis in all t(2;5) and t(3;5) cases. We were able to identify more accurately the site of the breakpoint in each case using the YACs surrounding the NPM region. As expected, a signal was observed on derivative chromosome 5 with the YACs which were centromeric to the breakpoint (928F1, 756A7, 942H4) and on derivative chromosome 2 or 3 with the YACs which were more telomeric (912B5, 887F10) ( Figure 1 , Table 1 ).
In case A with a t(2;5), a double signal was obtained on both derivatives with YACs amply overlapping the breakpoint (925F9, 885A6) (Figure 2a ). In the other t(2;5) case (case B), a signal was found only on derivative 5 using the same YACs, b a even after observation with the CCD camera ( Table 1 ). Assuming that Alu-PCR amplification did not totally restitute the human inserts of the YACs, we tested a probe from 925F9 obtained after DOP-PCR. The same results were obtained with this probe. RT-PCR allowed us to confirm that the NPM gene was indeed implicated in this t(2;5). Under these circumstances, the most plausible explanation was the presence of an interstitial microdeletion on derivative 2 associated with translocation 2;5 in case B.
Similarly, in cases C and D with t(3;5), a signal was obtained on normal chromosome 5 and on derivative 5 with YACs 925F9 and 885A6, but not on der(3) (Figure 2b ). In these cases, mRNA could not be extracted, so RTıPCR could not be performed. The YAC 61D1, covering the 630 kb around STS D5S653, was localized downstream of D5S625 and upstream of D5S462 (Figure 1 ). It exhibited only one signal on der (5) indicating that the breakpoint was localized at 5q35 and, as expected, in the NPM region. Therefore, we thought that an interstitial microdeletion on the der(3) associated with the 3;5 translocation was present.
These deletions on partner chromosomes were too small to be detected by banding techniques and chromosome painting and of course would not have been detected by RT-PCR which recognizes only the hybrid genes on derivative 5.
Such microdeletions associated with translocations were recently reported for chromosome 12 in various hematologic malignant diseases using FISH techniques 13 and in translocations involving the MLL gene at 11q23. 14, 15 The molecular and clinical significance of such chromosomal abberrations are still to be elucidated.
Interestingly, the MLL and NPM genes present some similarities: both are involved in myeloid and lymphoid malignancies and, like MLL, 16, 17 NPM is modified by different translocations: with ALK at 2p23 in ALCL, 3 with MLF1 at 3q25.1 in ANLL and MDS, 8 and with RAR␣ at 17q12 in acute promyelocytic leukemia. 18 This study shows that it is possible to rapidly diagnose t(2;5) and t(3;5) and any associated microdeletions using YACs 885A6 or 925F9 and 912B5 as probes. FISH techniques with these probes successfully complement classic cytogenetic and molecular techniques for the detection and characterization of complex rearrangements.
